Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)
China
· Delayed Price · Currency is CNY 192.83
-1.89 (-0.97%)
Jan 27, 2025, 4:00 PM CST
Sichuan Biokin Pharmaceutical Co.,Ltd. Revenue
Sichuan Biokin Pharmaceutical Co.,Ltd. had revenue of 109.83M CNY in the quarter ending September 30, 2024, with 64.78% growth. This brings the company's revenue in the last twelve months to 5.85B, up 873.42% year-over-year. In the year 2023, Sichuan Biokin Pharmaceutical Co.,Ltd. had annual revenue of 561.87M, down -20.11%.
Revenue (ttm)
5.85B
Revenue Growth
+873.42%
P/S Ratio
13.16
Revenue / Employee
2.80M
Employees
2,086
Market Cap
77.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
| Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
| Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
| Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
| Dec 31, 2019 | 1.21B | 788.57M | 188.63% |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 26.00B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Shanghai United Imaging Healthcare | 10.93B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |